Molbio Diagnostics Reappoints K.S. Kamalakara & Co as Cost Auditor for FY27
Molbio Diagnostics Ltd 路 Outcome 路 25 Sept 2026, 6:59 pm
Molbio Diagnostics Reappoints K.S. Kamalakara & Co as Cost Auditor for FY27 Molbio Diagnostics Limited's Board of Directors approved the reappointment of Bengaluru-based M/s K. S. Kamalakara & Co, Cost Accountants (FRN: 000296), as the company's Cost Auditors during its meeting on 25th Sep'26. The peer-reviewed firm, led by founding partner CMA K. S. Kamalakara, will conduct the audit of the company's cost accounts for FY27.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 路 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company 路 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. 路 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 路 06 Nov 2026
- Investor presentation 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. 路 05 Nov 2026
